App-Quantinova.ai

High minute volume pulmonary hypertension reversed by thiamine administration in wet Beriberi

Felipe Julio Chertcoff - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

Thiamine (vitamin B1)

Outcome of patients with acute symptomatic pulmonary embolism and psychiatric disorders

Diurbis Josefina Velasco Álvarez - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

Direct oral anticoagulants and low-molecular weight heparin for primary prevention of venous thromboembolism in cancer patients: a meta-analysis

Anna Francesca Mulles - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

Heparin

Venous thromboembolism prophylaxis in hospitals in China: a nationwide survey

Kaiyuan Zhen - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

Intermediate High Risk (IHR PE: The value of a PE Lysis Team (PELT

Charlotte Carter - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

Heparin

Utility of the Simplified Pesi Scale in Elderly Patients with Acute Symptomatic Pulmonary Thromboembolism

Carmen Rodriguez Calle - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

Venous thromboembolism in solid-organ transplant recipients: findings from the RIETE registry

Alberto Garcia Ortega - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

Does platelet index examination provide clinical benefit in coexistence of pulmonary thromboembolism and cancer?

Nesrin Öcal - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

Could pulmonary thromboembolism be associated with air pollution ?

Merve Atilgan Ala - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

N/A

Chronic thromboembolic pulmonary hypertension in acute pulmonary embolism: A risk factor evaluation study

Silan Isik - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Pulmonary thromboembolism in childhood: Six years of single center experience

Gizem Özcan - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

Predictors of Residual Pulmonary Vascular Obstruction after Pulmonary Embolism: results from a prospective cohort study

Francis Couturaud - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

Pregnancy, delivery and neonatal outcomes among women with an arcuate uterus, a large American population based study

E M Gangbe - European Society for Human Reproduction and Embryology (ESHRE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Venous thrombosis

N/A

The effect of endometriosis on placental histopathology and perinatal outcome in singleton live births resulting from in vitro fertilization

A Volodarsky-Perel - European Society for Human Reproduction and Embryology (ESHRE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Venous thrombosis

N/A

Differential levels of novel and classic antiphospholipid antibodies among patients with primary antiphospholipid syndrome and systemic lupus erythematosus

J.A. Gómez-Puerta - European League Against Rheumatism (EULAR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

Phosphatidylserine

A population-based study on the prevalence and incidence of vascular primary antiphospholipid syndrome: a new rare disease

C. Nalli - European League Against Rheumatism (EULAR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

N/A

A validation study of the pregnancy morbidity questionnaire(PMQ in women with antiphospholipid antibodies and pregnancy morbidity

K. Schreiber - European League Against Rheumatism (EULAR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

N/A

Cerebral venous thrombosis occurrence in systemic lupus erythematosus without anti-phospholipid antibody syndrome: a monocentric serie of 10 cases

Z. Lepine - European League Against Rheumatism (EULAR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

N/A

does abatacept increase perioperative adverse events in patients with rheumatoid arthritis compared with conventional synthetic disease modifying drugs? - a retrospective multicenter nested case-control study

H. Ito - European League Against Rheumatism (EULAR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

Abatacept

Histological and serological characteristics contribute to divergent outcomes for indigenous patients with lupus nephritis

J. Nossent - European League Against Rheumatism (EULAR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

N/A

Filters

7277 Abstracts